Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Uganda has declared an end to the Ebola outbreak that began earlier this year in Kampala, the nation’s capital city.

Ervebo is a recombinant, replication-competent Ebola vaccine, originally developed by NewLink Genetics and licensed to Merck in 2014, that has been given to hundreds of thousands of people in the ...

View Full Profile. Learn about our Editorial Policies. Ervebo, an Ebola vaccine from Merck, received marketing approval from the European Commission today (November 11), marking the first such vaccine ...

This is the second Ebola vaccine approved by the European Commission: in November it granted a marketing authorisation to MSD’s vaccine known as Ervebo. This vaccine has been shown to produce ...

Vaccines have been increasingly important in curbing recent Ebola outbreaks. Health authorities vaccinated more than 1,800 people using Merck's (MRK.N) ERVEBO vaccine amid the last flare-up.

Over the past month there have been numerous news reports regarding the Ugandan outbreak of Ebola virus hemorrhagic fever. As of 8 November, the Ugandan ministry of health reported 286 cases ...